Phoenix, AZ, October 24, 2005-The International Genomics Consortium's (IGC) Expression Project for Oncology (expO) today announced that it has collected its 1,000th frozen cancer specimen, which ...
PHILADELPHIA--(BUSINESS WIRE)--The National Disease Research Interchange (NDRI), in collaboration with Children’s Hospital of Philadelphia (CHOP), the University of Maryland’s Medicine Department of ...
The success of recombinant protein expression depends on selecting the right protein expression system. Target protein properties, intended applications, protein yield, as well as cost, must all be ...
Expressing recombinant antibodies in mammalian cells is essential when post-translational alterations and proper folding are required for downstream applications. The most common problems of antibody ...
Researchers and companies are devising promising approaches to circumvent limitations of existing transfection technologies. Ongoing challenges, particularly with regard to high-quality recombinant ...
Gene dysregulation is a hallmark of disease, driving pathogenic phenotypes and poor patient outcomes. RNA binding proteins are often important human gene effectors, controlling RNA synthesis, ...